Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-09

AUTHORS

Jonas Manjer, Robert Johansson, Göran Berglund, Lars Janzon, Rudolf Kaaks, Åsa Ågren, Per Lenner

ABSTRACT

Objective: High levels of sex steroid hormones and prolactin have been suggested to enhance breast cancer development. Low levels of SHBG may indicate high levels of (bio-available) steroid hormones. The present study investigates whether high levels of sex steroid hormones and prolactin, and/or low levels of SHBG, are associated with high breast cancer risk. Methods: Blood samples were collected in about 65,000 women participating in two population-based prospective cohort studies in Sweden. Follow-up yielded 173 postmenopausal breast cancer cases who had not been exposed to HRT. Levels of estrone, estradiol, SHBG, FSH, prolactin, testosterone, androstenedione and DHEAs were analysed in cases and 438 controls. Logistic regression analysis yielded odds ratios (ORs), with 95% confidence intervals, adjusted for potential confounders. Results: The risk of breast cancer was associated with the highest versus lowest quartiles of estrone, OR: 2.58 (1.50–4.44), estradiol (dichotomised: high versus low) (1.73: 1.04–2.88), and testosterone (1.87: 1.08–3.25). High risks, although not statistically significant, were seen for androstenedione (1.58: 0.92–2.72) and DHEAs (1.62: 0.89–2.72). No strong associations were seen between SHBG or prolactin and risk of breast cancer. Conclusions: High levels of estrone, estradiol, testosterone, and possibly androstenedione and DHEAs, in postmenopausal women are associated with a high risk of subsequent breast cancer. More... »

PAGES

599-607

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1025671317220

DOI

http://dx.doi.org/10.1023/a:1025671317220

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006873086

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/14575357


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Androstenedione", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dehydroepiandrosterone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Estradiol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Estrone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gonadal Steroid Hormones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Logistic Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prolactin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sex Hormone-Binding Globulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sweden", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Testosterone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Community Medicine, Malm\u00f6 University Hospital, Malm\u00f6, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.411843.b", 
          "name": [
            "Department of Community Medicine, Malm\u00f6 University Hospital, Malm\u00f6, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manjer", 
        "givenName": "Jonas", 
        "id": "sg:person.01001561122.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001561122.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncologic Centre, Norrland University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Oncologic Centre, Norrland University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Johansson", 
        "givenName": "Robert", 
        "id": "sg:person.01036250535.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036250535.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Malm\u00f6 University Hospital, Malm\u00f6, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.411843.b", 
          "name": [
            "Department of Medicine, Malm\u00f6 University Hospital, Malm\u00f6, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berglund", 
        "givenName": "G\u00f6ran", 
        "id": "sg:person.01313726246.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313726246.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Community Medicine, Malm\u00f6 University Hospital, Malm\u00f6, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.411843.b", 
          "name": [
            "Department of Community Medicine, Malm\u00f6 University Hospital, Malm\u00f6, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Janzon", 
        "givenName": "Lars", 
        "id": "sg:person.01051311312.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051311312.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IARC, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.17703.32", 
          "name": [
            "IARC, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaaks", 
        "givenName": "Rudolf", 
        "id": "sg:person.015420102437.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015420102437.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Medical Bank, Norrland University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "The Medical Bank, Norrland University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "\u00c5gren", 
        "givenName": "\u00c5sa", 
        "id": "sg:person.01316513510.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316513510.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncologic Centre, Norrland University Hospital, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Oncologic Centre, Norrland University Hospital, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lenner", 
        "givenName": "Per", 
        "id": "sg:person.0721051037.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721051037.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1996.304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034863842", 
          "https://doi.org/10.1038/bjc.1996.304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1997.398", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028090902", 
          "https://doi.org/10.1038/bjc.1997.398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00051703", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010664099", 
          "https://doi.org/10.1007/bf00051703"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-09", 
    "datePublishedReg": "2003-09-01", 
    "description": "Objective: High levels of sex steroid hormones and prolactin have been suggested to enhance breast cancer development. Low levels of SHBG may indicate high levels of (bio-available) steroid hormones. The present study investigates whether high levels of sex steroid hormones and prolactin, and/or low levels of SHBG, are associated with high breast cancer risk. Methods: Blood samples were collected in about 65,000 women participating in two population-based prospective cohort studies in Sweden. Follow-up yielded 173 postmenopausal breast cancer cases who had not been exposed to HRT. Levels of estrone, estradiol, SHBG, FSH, prolactin, testosterone, androstenedione and DHEAs were analysed in cases and 438 controls. Logistic regression analysis yielded odds ratios (ORs), with 95% confidence intervals, adjusted for potential confounders. Results: The risk of breast cancer was associated with the highest versus lowest quartiles of estrone, OR: 2.58 (1.50\u20134.44), estradiol (dichotomised: high versus low) (1.73: 1.04\u20132.88), and testosterone (1.87: 1.08\u20133.25). High risks, although not statistically significant, were seen for androstenedione (1.58: 0.92\u20132.72) and DHEAs (1.62: 0.89\u20132.72). No strong associations were seen between SHBG or prolactin and risk of breast cancer. Conclusions: High levels of estrone, estradiol, testosterone, and possibly androstenedione and DHEAs, in postmenopausal women are associated with a high risk of subsequent breast cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1025671317220", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100917", 
        "issn": [
          "0957-5243", 
          "1573-7225"
        ], 
        "name": "Cancer Causes & Control", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "sex steroid hormones", 
      "breast cancer risk", 
      "breast cancer", 
      "steroid hormones", 
      "odds ratio", 
      "cancer risk", 
      "high risk", 
      "population-based prospective cohort study", 
      "postmenopausal breast cancer risk", 
      "postmenopausal breast cancer cases", 
      "higher breast cancer risk", 
      "prospective cohort study", 
      "subsequent breast cancer", 
      "levels of estrone", 
      "breast cancer development", 
      "breast cancer cases", 
      "logistic regression analysis", 
      "cohort study", 
      "postmenopausal women", 
      "potential confounders", 
      "lowest quartile", 
      "cancer cases", 
      "blood samples", 
      "high levels", 
      "SHBG", 
      "prolactin", 
      "cancer development", 
      "DHEA", 
      "low levels", 
      "estradiol", 
      "androstenedione", 
      "testosterone", 
      "hormone", 
      "cancer", 
      "strong association", 
      "confidence intervals", 
      "risk", 
      "regression analysis", 
      "estrone", 
      "women", 
      "present study", 
      "levels", 
      "FSH", 
      "confounders", 
      "quartile", 
      "cases", 
      "study", 
      "association", 
      "interval", 
      "control", 
      "HRT", 
      "Sweden", 
      "samples", 
      "development", 
      "ratio", 
      "analysis", 
      "relation"
    ], 
    "name": "Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)", 
    "pagination": "599-607", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006873086"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1025671317220"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "14575357"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1025671317220", 
      "https://app.dimensions.ai/details/publication/pub.1006873086"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_364.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1025671317220"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1025671317220'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1025671317220'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1025671317220'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1025671317220'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      104 URIs      92 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1025671317220 schema:about N1b893d34b3ef4fb9999ea3a3c56ca75e
2 N2baa0548930e4af9b3a8431b29a7de15
3 N2def40bd898e405691d68eea2c345ef9
4 N45598fd625f34f7faa8492fae97d37a7
5 N6c3bd9f4d3e8448baa86bf0590449ef8
6 N6f9a7956b9184c84a1c80033a38f6a87
7 N8df7f8a3d35942639986c870d414b8d3
8 Na7cf1c46914f43d297d53f5b1390bbbb
9 Na87283f269474c51b534af90fc28ddee
10 Nb758ff83b95f4b51a31455dd36b9815b
11 Nc712cbab0de94760a87294cd2d44dd43
12 Ndcafdf077a3346519125a1cc2e01967a
13 Ne83379f28f4e4538a0f58efd49bb934a
14 Nea070b58a7914d8c96ec630a2431bc02
15 Nfa05111608454f99836cd204a8b337f4
16 Nfa24d81f499743d287671069f7a0dc91
17 Nfefc8d8c8b934a96942f574e60943725
18 anzsrc-for:11
19 anzsrc-for:1112
20 anzsrc-for:1117
21 schema:author Na68a2667367c4fcc8cc57dcf289de29e
22 schema:citation sg:pub.10.1007/bf00051703
23 sg:pub.10.1038/bjc.1996.304
24 sg:pub.10.1038/bjc.1997.398
25 schema:datePublished 2003-09
26 schema:datePublishedReg 2003-09-01
27 schema:description Objective: High levels of sex steroid hormones and prolactin have been suggested to enhance breast cancer development. Low levels of SHBG may indicate high levels of (bio-available) steroid hormones. The present study investigates whether high levels of sex steroid hormones and prolactin, and/or low levels of SHBG, are associated with high breast cancer risk. Methods: Blood samples were collected in about 65,000 women participating in two population-based prospective cohort studies in Sweden. Follow-up yielded 173 postmenopausal breast cancer cases who had not been exposed to HRT. Levels of estrone, estradiol, SHBG, FSH, prolactin, testosterone, androstenedione and DHEAs were analysed in cases and 438 controls. Logistic regression analysis yielded odds ratios (ORs), with 95% confidence intervals, adjusted for potential confounders. Results: The risk of breast cancer was associated with the highest versus lowest quartiles of estrone, OR: 2.58 (1.50–4.44), estradiol (dichotomised: high versus low) (1.73: 1.04–2.88), and testosterone (1.87: 1.08–3.25). High risks, although not statistically significant, were seen for androstenedione (1.58: 0.92–2.72) and DHEAs (1.62: 0.89–2.72). No strong associations were seen between SHBG or prolactin and risk of breast cancer. Conclusions: High levels of estrone, estradiol, testosterone, and possibly androstenedione and DHEAs, in postmenopausal women are associated with a high risk of subsequent breast cancer.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf N0ebf1c3d9fe64ab6887e186b4ef2979c
31 Ndcf8b1e26daf4738b06173519e86b157
32 sg:journal.1100917
33 schema:keywords DHEA
34 FSH
35 HRT
36 SHBG
37 Sweden
38 analysis
39 androstenedione
40 association
41 blood samples
42 breast cancer
43 breast cancer cases
44 breast cancer development
45 breast cancer risk
46 cancer
47 cancer cases
48 cancer development
49 cancer risk
50 cases
51 cohort study
52 confidence intervals
53 confounders
54 control
55 development
56 estradiol
57 estrone
58 high levels
59 high risk
60 higher breast cancer risk
61 hormone
62 interval
63 levels
64 levels of estrone
65 logistic regression analysis
66 low levels
67 lowest quartile
68 odds ratio
69 population-based prospective cohort study
70 postmenopausal breast cancer cases
71 postmenopausal breast cancer risk
72 postmenopausal women
73 potential confounders
74 present study
75 prolactin
76 prospective cohort study
77 quartile
78 ratio
79 regression analysis
80 relation
81 risk
82 samples
83 sex steroid hormones
84 steroid hormones
85 strong association
86 study
87 subsequent breast cancer
88 testosterone
89 women
90 schema:name Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
91 schema:pagination 599-607
92 schema:productId N1b788349b6a94192a773f7fe0b538713
93 Ncba4839ab7cf4554922718410952baae
94 Nd3deba874a424fb493837ef01ce8f42a
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006873086
96 https://doi.org/10.1023/a:1025671317220
97 schema:sdDatePublished 2022-10-01T06:32
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N6bb5f12237d944dbb27921184a8ea471
100 schema:url https://doi.org/10.1023/a:1025671317220
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N0ebf1c3d9fe64ab6887e186b4ef2979c schema:issueNumber 7
105 rdf:type schema:PublicationIssue
106 N162a9949817846c785679e30e104a4b1 rdf:first sg:person.0721051037.52
107 rdf:rest rdf:nil
108 N1b788349b6a94192a773f7fe0b538713 schema:name dimensions_id
109 schema:value pub.1006873086
110 rdf:type schema:PropertyValue
111 N1b893d34b3ef4fb9999ea3a3c56ca75e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Testosterone
113 rdf:type schema:DefinedTerm
114 N2baa0548930e4af9b3a8431b29a7de15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Sweden
116 rdf:type schema:DefinedTerm
117 N2def40bd898e405691d68eea2c345ef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Dehydroepiandrosterone
119 rdf:type schema:DefinedTerm
120 N3c47e57b232f47da9052f3a8594e73ce rdf:first sg:person.01051311312.39
121 rdf:rest N9d45dc5335914869849785342c5e3723
122 N45598fd625f34f7faa8492fae97d37a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Gonadal Steroid Hormones
124 rdf:type schema:DefinedTerm
125 N4639e5f7e9b248a68b8240a74a2504aa rdf:first sg:person.01313726246.87
126 rdf:rest N3c47e57b232f47da9052f3a8594e73ce
127 N6bb5f12237d944dbb27921184a8ea471 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 N6c3bd9f4d3e8448baa86bf0590449ef8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Prolactin
131 rdf:type schema:DefinedTerm
132 N6f9a7956b9184c84a1c80033a38f6a87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Middle Aged
134 rdf:type schema:DefinedTerm
135 N8c32f9947bc3464688d474f64fc79aa2 rdf:first sg:person.01036250535.82
136 rdf:rest N4639e5f7e9b248a68b8240a74a2504aa
137 N8df7f8a3d35942639986c870d414b8d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Risk Factors
139 rdf:type schema:DefinedTerm
140 N9235c0cc09c4459ea6c36d2becf427bf rdf:first sg:person.01316513510.20
141 rdf:rest N162a9949817846c785679e30e104a4b1
142 N9d45dc5335914869849785342c5e3723 rdf:first sg:person.015420102437.43
143 rdf:rest N9235c0cc09c4459ea6c36d2becf427bf
144 Na68a2667367c4fcc8cc57dcf289de29e rdf:first sg:person.01001561122.12
145 rdf:rest N8c32f9947bc3464688d474f64fc79aa2
146 Na7cf1c46914f43d297d53f5b1390bbbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Androstenedione
148 rdf:type schema:DefinedTerm
149 Na87283f269474c51b534af90fc28ddee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Estradiol
151 rdf:type schema:DefinedTerm
152 Nb758ff83b95f4b51a31455dd36b9815b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Humans
154 rdf:type schema:DefinedTerm
155 Nc712cbab0de94760a87294cd2d44dd43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Breast Neoplasms
157 rdf:type schema:DefinedTerm
158 Ncba4839ab7cf4554922718410952baae schema:name pubmed_id
159 schema:value 14575357
160 rdf:type schema:PropertyValue
161 Nd3deba874a424fb493837ef01ce8f42a schema:name doi
162 schema:value 10.1023/a:1025671317220
163 rdf:type schema:PropertyValue
164 Ndcafdf077a3346519125a1cc2e01967a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Estrone
166 rdf:type schema:DefinedTerm
167 Ndcf8b1e26daf4738b06173519e86b157 schema:volumeNumber 14
168 rdf:type schema:PublicationVolume
169 Ne83379f28f4e4538a0f58efd49bb934a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Logistic Models
171 rdf:type schema:DefinedTerm
172 Nea070b58a7914d8c96ec630a2431bc02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Case-Control Studies
174 rdf:type schema:DefinedTerm
175 Nfa05111608454f99836cd204a8b337f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Sex Hormone-Binding Globulin
177 rdf:type schema:DefinedTerm
178 Nfa24d81f499743d287671069f7a0dc91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Female
180 rdf:type schema:DefinedTerm
181 Nfefc8d8c8b934a96942f574e60943725 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Prospective Studies
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
188 schema:name Oncology and Carcinogenesis
189 rdf:type schema:DefinedTerm
190 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
191 schema:name Public Health and Health Services
192 rdf:type schema:DefinedTerm
193 sg:journal.1100917 schema:issn 0957-5243
194 1573-7225
195 schema:name Cancer Causes & Control
196 schema:publisher Springer Nature
197 rdf:type schema:Periodical
198 sg:person.01001561122.12 schema:affiliation grid-institutes:grid.411843.b
199 schema:familyName Manjer
200 schema:givenName Jonas
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001561122.12
202 rdf:type schema:Person
203 sg:person.01036250535.82 schema:affiliation grid-institutes:grid.412215.1
204 schema:familyName Johansson
205 schema:givenName Robert
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036250535.82
207 rdf:type schema:Person
208 sg:person.01051311312.39 schema:affiliation grid-institutes:grid.411843.b
209 schema:familyName Janzon
210 schema:givenName Lars
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051311312.39
212 rdf:type schema:Person
213 sg:person.01313726246.87 schema:affiliation grid-institutes:grid.411843.b
214 schema:familyName Berglund
215 schema:givenName Göran
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313726246.87
217 rdf:type schema:Person
218 sg:person.01316513510.20 schema:affiliation grid-institutes:grid.412215.1
219 schema:familyName Ågren
220 schema:givenName Åsa
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316513510.20
222 rdf:type schema:Person
223 sg:person.015420102437.43 schema:affiliation grid-institutes:grid.17703.32
224 schema:familyName Kaaks
225 schema:givenName Rudolf
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015420102437.43
227 rdf:type schema:Person
228 sg:person.0721051037.52 schema:affiliation grid-institutes:grid.412215.1
229 schema:familyName Lenner
230 schema:givenName Per
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721051037.52
232 rdf:type schema:Person
233 sg:pub.10.1007/bf00051703 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010664099
234 https://doi.org/10.1007/bf00051703
235 rdf:type schema:CreativeWork
236 sg:pub.10.1038/bjc.1996.304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034863842
237 https://doi.org/10.1038/bjc.1996.304
238 rdf:type schema:CreativeWork
239 sg:pub.10.1038/bjc.1997.398 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028090902
240 https://doi.org/10.1038/bjc.1997.398
241 rdf:type schema:CreativeWork
242 grid-institutes:grid.17703.32 schema:alternateName IARC, Lyon, France
243 schema:name IARC, Lyon, France
244 rdf:type schema:Organization
245 grid-institutes:grid.411843.b schema:alternateName Department of Community Medicine, Malmö University Hospital, Malmö, Sweden
246 Department of Medicine, Malmö University Hospital, Malmö, Sweden
247 schema:name Department of Community Medicine, Malmö University Hospital, Malmö, Sweden
248 Department of Medicine, Malmö University Hospital, Malmö, Sweden
249 rdf:type schema:Organization
250 grid-institutes:grid.412215.1 schema:alternateName Oncologic Centre, Norrland University Hospital, Umeå, Sweden
251 The Medical Bank, Norrland University Hospital, Umeå, Sweden
252 schema:name Oncologic Centre, Norrland University Hospital, Umeå, Sweden
253 The Medical Bank, Norrland University Hospital, Umeå, Sweden
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...